Abstract | BACKGROUND: METHODS: Ninety-six patients with limited aggressive periodontitis were selected and randomly divided into two groups. Forty-eight patients in the control group were treated with xipayi mouth rinse after primary periodontal treatment. Then, 48 patients in the experimental group were treated with xipayi mouth rinse combined with minocycline after primary periodontal treatment. The periodontal probe was applied to detect periodontal plaque index (PLI), periodontal pocket depth (PD), sulcus bleeding index (SBI), gingival index (GL), and clinical attachment loss (CAL) before and after treatment in both groups of patients. ELISA was used for detecting the expression levels of CRP, TNF-α, and IL-6 in the serum of patients in two groups before and after treatment. We compared the recurrence rates of the two groups after a 1-year follow-up. RESULTS: Compared with the control group, the PLI, PD, SBI, GL, CAL, and total masticatory efficiency of the experimental group were significantly better than those of the control group. The levels of inflammatory factors CRP, TNF-α, and IL-6 were significantly declined, and the total effective rate of treatment was significantly elevated. After follow-up, it was found there was no noticeable difference in the recurrence rate between the two groups. CONCLUSIONS: Xipayi mouth rinse, combined with minocycline in the treatment of localized aggressive periodontitis, can significantly improve the periodontal gingival condition and reduce the level of inflammatory factors. Also, the efficacy of the treatment was significant. This experiment has provided ideas for improving the clinical treatment of patients with localized aggressive periodontitis.
|
Authors | Xian Chen, Li Wang, Zhifang He, Haijiao Zhao, Yehua Cai, Shanglin Song, Qin Yu |
Journal | Annals of palliative medicine
(Ann Palliat Med)
Vol. 9
Issue 5
Pg. 3410-3417
(Sep 2020)
ISSN: 2224-5839 [Electronic] China |
PMID | 33065791
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Interleukin-6
- Mouthwashes
- Tumor Necrosis Factor-alpha
- Minocycline
|
Topics |
- Adult
- Aggressive Periodontitis
(drug therapy)
- Humans
- Interleukin-6
- Minocycline
(therapeutic use)
- Mouthwashes
(therapeutic use)
- Quality of Life
- Tumor Necrosis Factor-alpha
|